World Molecular Diagnostics Tests Market Report 2022: COVID-19, Sequencing, CRISPR, Automation Sequencing, Competitive Landscape - Forecasts to 2027
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "The World Market for Molecular Diagnostics Tests, 11th Edition" report has been added to ResearchAndMarkets.com's offering.
In this report, our industry experts and top analysts assess the current positions of this complex market, which has an estimated value of more than $21 billion.
The report provides marketing sizing and forecasts for in vitro diagnostics (IVDs) over a five-year period.
This data publication has become an indispensable tool in clinical healthcare medicine and assesses the business opportunity, new product introductions, and rapid changes in several areas of this industry, including:
Infectious Disease Molecular Diagnostics (COVID-19, Hepatitis, HIV, Respiratory, STI, Others)
Cancer Molecular Diagnostic Markets (Blood-based and Tissue-based)
Genetic Molecular Diagnostic Markets (SNPs, Inherited, NIPT, Other)
Blood Banking Molecular Diagnostics Markets
Transplantation Molecular Diagnostic Markets
Regional Molecular Diagnostics Markets (North America, Europe, Asia, Global)
Molecular diagnostics proved their value during the COVID-19 pandemic, but the heavily competitive market in 2022 demonstrates that market leaders need to anticipate quick and rapid changes.
Get a needed jumpstart on market positioning for your business in 2023 and purchase your copy today.
Key Topics Covered:
CHAPTER 1: EXECUTIVE SUMMARY
MOLECULAR DIAGNOSTICS IN THE SPOTLIGHT
Molecular Diagnostics Market (w COVID-19 and w/out COVID-19, 2021 ($B)
Hundreds of PCR Tests on the Market, U.S. Labs Settle on a Few
COVID-19 Molecular Testing Market, First Half-Year 2020, Full Year 2020, and Q 2021 ($M)
Estimated COVID-19 Molecular Diagnostic Revenue, Q1 2020-Q1 2021 COVID-19 Market
EMERGING TRENDS
Automation
Market-Available Molecular POC Diagnostic Platforms Molecular Point of Care
Next-Generation Sequencing on the Rise
LDT Regulation and COVID-19
Reimbursement Environment
Thermo and Qiagen Merger
Complementary diagnostic products offered by Thermo Fisher, Qiagen
CRISPR, Sequencing and COVID-19
THE GLOBAL MOLECULAR DIAGNOSTICS MARKET IN THE ERA OF COVID-19
Non-COVID-19 Molecular Diagnostics Market, 2020-2026 ($M)
CHAPTER 2: COVID-19 MOLECULAR DIAGNOSTIC MARKET ANALYSIS
MAJOR IVD PLAYERS SEE BRISK COVID-19 TEST SALES
COVID-19 Molecular Detection Tests from Major Suppliers
COVID-19 Molecular Diagnostics Monthly Volume
COVID-19 Molecular Diagnostics Monthly Test Volume
COVID-19 Molecular Diagnostics Revenues by Region Estimated: North America, Europe, APAC, ROW, LATAM, World, Q1 2020-Q1 2021 (in $)
COVID-19 Molecular Diagnostics Shares by Region Estimated: North America, Europe, APAC, ROW, LATAM, World, 2020-Q1 2021 (%)
COVID-19 Molecular Diagnostics Estimated Revenue by Region
COVID-19 Revenue Shares by Region
NORTH AMERICA
COVID-19 Tests, North America (early June 2021)
USA - New Cases per Day
USA Daily Testing Volume
Canada - New Cases per Day
Canada Daily Testing Volume
EUROPE
APAC
LATIN AMERICA
REST-OF-WORLD
COVID TESTING MARKET COMPUTATION METHODOLOGY
TEST VENDORS
Other PCR Tests Products on the Market
TESTING TRENDS, RECOMMENDATIONS, AND CONSENSUS TAKING SHAPE
CHAPTER 3: MARKETS FOR OTHER MOLECULAR DIAGNOSTIC TESTS
Molecular Diagnostic Market, 2021 and 2026 by Category ($M)
Molecular Diagnostic (non-COVID) Market, by Region 2021 ($M)
Molecular Diagnostics (non-COVID) Market by Region 2021 ($M)
RECENT PRODUCT INTRODUCTIONS AND REGULATORY APPROVALS
Recent Product Introduction
Recent Regulatory Approvals and Related Announcements
INFECTIOUS DISEASES
Respiratory Diseases: COVID-19 Impact
Mycobacteria/Tuberculosis: Market and COVID-19 Impact
Product Developments
Hospital-Acquired Infections (HAIs): Market and COVID-19 Impact
COVID as a hospital infection?
Vendors
Sexually Transmitted Infections: Market and COVID-19 Impact
Increased Vendor Activity in Molecular Trichomoniasis vaginalis (TV)
Hepatitis: COVID-19 Impact
New HCV Screening Guidelines
Selected Molecular Hepatitis Tests
HIV Market and COVID-19 Impact
Selected Molecular Test Products for HIV
NAT BLOOD SCREENING
COVID-19 Impact
Other Trends
Declining Blood Transfusions in Developed Markets
MOLECULAR HISTOLOGY AND CYTOLOGY DIAGNOSTICS
COVID-19 Impact
HPV
Eliminating HPV Threat? Lancet Public Health Study
COVID-19 Impact
Product Developments
MARKETS FOR MOLECULAR CANCER DIAGNOSTICS
Cancer Molecular Blood Markers - COVID-19 Impact
Other Trends
Liquid Biopsy
MOLECULAR TRANSPLANT DIAGNOSTICS
COVID-19
Selected Innovations in the Field of Molecular Transplant Diagnostics
MOLECULAR INHERITED DISEASES DIAGNOSTICS
Inherited Diseases - COVID-19 Impact
Thrombophilia and Coagulation Markers
Non-Invasive Prenatal Testing (NIPT)
Promising NIPT Studies
Inherited Disease Tests
MOLECULAR DIAGNOSTICS MARKET DEALS, COLLABORATIONS, ACQUISITIONS
Selected Deals
CHAPTER 4: TRENDS TO WATCH - SEQUENCING, CRISPR, AUTOMATION SEQUENCING
Avoiding New Waves of Infection
COVID and NGS
NGS and Inherited Disease
NGS and Companion Diagnostics
Selected Clinical NGS Platforms in the Market
Outlook For NGS in Molecular Diagnostics
Percent of the MDX Market Revenues for Tests Using NGS 2020 and 2025
Evolving Informatics Solutions in Clinical Sequencing
Sample Preparation and Quality Control
LAB AUTOMATION AND MOLECULAR DIAGNOSTICS
Selected Automated Molecular Test Instrument Platforms
Selected FDA Declared EUA Tests
CRISPR AND MOLECULAR DIAGNOSTICS
CRISPR Innovations CRISPR and COVID-19
CHAPTER 5: COMPANY PROFILES
Companies
Abbott Diagnostics
Advanced Cell Diagnostics (Biotechne)
Agena Bioscience
Agendia Bv
Agilent Technologies (Incl. Dako)
Aidian Oy
Altona Diagnostics
Amoy Diagnostics
Arup Laboratories
Asuragen Inc. (Bio-Techne)
Bd Interventional
Bd Life Sciences
Bd Medical
Becton, Dickinson & Co. (BD)
Beijing Genomics Institute (Bgi)
Berry Genomics
Binx Health
Bio-Rad Laboratories, Inc.
Biocartis
Biodesix
Biomeme, Inc
bioMerieux
Bioneer
C. R. Bard, Inc.
Caredx, Inc.
Carefusion Corporation
Credo Bioscience
Ctk Biotech
Danaher (Cepheid and Leica Biosystems)
Diasorin
Eiken Chemical
Exact Sciences Corp.
Fluidigm Corporation
Genmark Diagnostics (Roche)
Genotypic Technology Pvt. Ltd.
Greiner Bio-One GmbH
Grifols, S. A
Hologic, Inc.
Illumina, Inc.
Immucor, Inc.
Meridian Bioscience Inc
Mesa Biotech, Inc. (Thermo)
Molbio Diagnostics Pvt. Ltd.
Myriad Genetics, Inc.
Nanostring Technologies, Inc.
Neuromodx
Oxford Nanopore Technologies Ltd
Perkinelmer Inc.
Prescient Medicine Holdings (Autogenomics)
Promega Corporation
Qiagen
QIAGEN N.V.
Quantumdx Group.
Quidel Corporation
Recent Acquisitions
Rheonix, Inc.
Roche Diagnostics
Seegene
Sekisui Diagnostics LLC
Sherlock Biosciences
T2 Biosystems
Thermo Fisher Scientific Inc.
Tva Medical, Inc.
Vela Diagnostics
Veracyte, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/fqmgo4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900